GlassScriptPhysician profile
Beverly M Vaughn
NPI 1568420529
$1,388.29
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $110 · 2021: $192 · 2022: $536 · 2023: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.54 | 2019-2023 | Orilissa |
| Myovant Sciences INC. | $162.95 | 2021-2022 | |
| Lupin INC. | $144.94 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.41 | 2022-2023 | |
| Coopersurgical, INC. | $76.91 | 2019-2022 | |
| Therapeuticsmd, INC. | $67.13 | 2019 | |
| Evofem Biosciences, INC. | $61.85 | 2022 | |
| Virtus Pharmaceuticals LLC | $59.28 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $57.82 | 2023 | Myfembree |
| Baxter Healthcare | $46.73 | 2019 | |
| Covidien LP | $37.93 | 2019-2020 | |
| Dysis Medical, INC. | $28.52 | 2019 | |
| Boston Scientific Corporation | $23.52 | 2023 | Advantage System |
| Roche Diagnostics Corporation | $22.81 | 2019 | |
| Medicem INC. | $20.52 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $18.55 | 2021 | |
| Medtronic, INC. | $16.44 | 2022 | |
| Merck Sharp & Dohme LLC | $14.89 | 2019 | |
| Millicent US INC | $14.42 | 2020 | |
| Hologic Sales and Service, LLC | $14.35 | 2020 | |
| Allergan, INC. | $13.09 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.